Press releaseGlobe Newswire
ImageneBio
IMA · NASDAQ
$4.13+$0.13 (+3.25%)TodayMarket closed ·
Prev close $4.00
Latest news
- Press releaseGlobe Newswire
ImageneBio Appoints Matt Robbins as General Counsel
- Press releaseGlobe Newswire
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
- NewsVandana Singh
ImageneBio $30 Million Private Placement Ignites Stock
- News
Market-Moving News for April 13th
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releaseGlobe Newswire
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
- Press releaseGlobe Newswire
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
- News
ImageneBio Announces It Intends To Submit Protocol Amendment For Phase 2b ADAPTIVE Study To Expand Number, Exposure Range Of Dosing Regiments, Optimize Feasibility Of Study
- Press releaseGlobe Newswire
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.